Mutational profiles of ovarian cancer in Chinese patients revealed potential therapeutic targets and prognostic markers.

被引：0
|
作者：
Feng, Weiwei
Lyu, Tianjiao
Liu, Hua
Jiang, Yahui
Shen, Lifei
Long, Wenqing
Zhu, Lan
Shao, Siqi
Ma, Jinyan
Wang, Jian
Zhou, Yuxi
Yang, Yuchen
机构：
[1] Shanghai Jiaotong Univ, Sch Med, Ruijin Hosp, Shanghai, Peoples R China
[2] Burning Rock Biotech, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
基金：
上海市自然科学基金;
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e17525
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17525
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis
    Zhang, Jing
    Huang, Shouguo
    Quan, Lini
    Meng, Qiu
    Wang, Haiyan
    Wang, Jie
    Chen, Jin
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [2] Distinct molecular profiles and potential therapeutic targets in androgen receptor stratified ovarian cancer patients
    Jones, N. L.
    Xiu, J.
    Scalici, J. M.
    Finan, M. A.
    Winer, I.
    Pierce, J. Young
    Rocconi, R. P.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 177 - 177
  • [3] MAGE-A family serves as poor prognostic markers and potential therapeutic targets for epithelial ovarian cancer patients: a retrospective clinical study
    Sang, Meixiang
    Wu, Xiaohua
    Fan, Xiaojie
    Lian, Yishui
    Sang, Meijie
    GYNECOLOGICAL ENDOCRINOLOGY, 2017, 33 (06) : 480 - 484
  • [4] The potential value of cancer-testis antigens in ovarian cancer: Prognostic markers and targets for immunotherapy
    Lin, Lina
    Zou, Xiaoqiong
    Nong, Weixia
    Ge, Yingying
    Li, Feng
    Luo, Bin
    Zhang, Qingmei
    Xie, Xiaoxun
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (06)
  • [5] The haemostatic state in cancer patients: The relationship between hypercoagulable markers and cancer prognostic markers.
    Mousa, SA
    Al-Tajer, S
    Alzadeh, H
    BLOOD, 2003, 102 (11) : 109B - 109B
  • [6] The hemostatic state in cancer patients: The relationship between hypercoagulable markers and cancer prognostic markers.
    Mousa, SA
    Alizadeh, H
    Al-Tajer, S
    BLOOD, 2004, 104 (11) : 92B - 93B
  • [7] Matrix metalloproteinases in cancer:: Prognostic markers and therapeutic targets
    Vihinen, P
    Kähäri, VM
    INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (02) : 157 - 166
  • [8] Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets
    Oto, Julia
    Le, Quang-Khoi
    Schaefer, Sebastian D.
    Kiesel, Ludwig
    Mari-Alexandre, Josep
    Gilabert-Estelles, Juan
    Medina, Pilar
    Goette, Martin
    CANCERS, 2023, 15 (12)
  • [9] Mutational Profiling of Malignant Mesothelioma Revealed Potential Therapeutic Targets in EGFR and NRAS
    Kim, Jeong Eun
    Kim, Deokhoon
    Hong, Yong Sang
    Kim, Kyu-pyo
    Yoon, Young Kwang
    Lee, Dae Ho
    Kim, Sang-We
    Chun, Sung-Min
    Jang, Se Jin
    Kim, Tae Won
    TRANSLATIONAL ONCOLOGY, 2018, 11 (02): : 268 - 274
  • [10] Gene Expression Profiles as Prognostic Markers in Women With Ovarian Cancer
    Jochumsen, Kirsten M.
    Tan, Qihua
    Hogdall, Estrid V.
    Hogdall, Claus
    Kjaer, Susanne K.
    Blaakaer, Jan
    Kruse, Torben A.
    Mogensen, Ole
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (07) : 1205 - 1213
12345